CIPLA AUSTRALIA PTY LTD, — Fluticasone Importer Profile
Pharmaceutical Importer · #11 buyer for Fluticasone · $1.5M import value · 48 shipments · AUSTRALIA · DGFT Verified
CIPLA AUSTRALIA PTY LTD, is the #11 importer of Fluticasone from India with $1.5M in import value and 48 verified shipments. CIPLA AUSTRALIA PTY LTD, holds a 0.7% market share in Fluticasone imports based in AUSTRALIA. The company sources from 1 verified supplier across 25 formulations shipped to 1 country. Overall, CIPLA AUSTRALIA PTY LTD, imports 3 pharmaceutical products worth $2.9M across 2 therapeutic categories.
CIPLA AUSTRALIA PTY LTD, — Fluticasone Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Fluticasone to CIPLA AUSTRALIA PTY LTD,?
Verified from 48 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $1.5M | 48 | 100.0% |
CIPLA AUSTRALIA PTY LTD, sources Fluticasone from 1 verified Indian supplier based on 48 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
How Does CIPLA AUSTRALIA PTY LTD, Compare to Nearest Fluticasone Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | MYLAN AUSTRALIA | AUSTRALIA | $1.7M | 34 | $50.0K |
| 15 | MEDPRO PHARMACEUTICA PTY LIMITED | SOUTH AFRICA | $1.6M | 33 | $50.0K |
| 11 | CIPLA AUSTRALIA PTY LTD, ★ | AUSTRALIA | $1.4M | 29 | $50.0K |
| 5 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | UNITED STATES | $1.3M | 25 | $50.0K |
| 17 | MYLAN BRASIL DISTRIBUIDORA DE MEDIC | BRAZIL | $750.0K | 15 | $50.0K |
CIPLA AUSTRALIA PTY LTD, ranks #11 among 664 Fluticasone importers from India. Average shipment value of $50.0K compared to the market average of $83.7K. The closest competitors by value are MYLAN AUSTRALIA and MEDPRO PHARMACEUTICA PTY LIMITED.
Where Does CIPLA AUSTRALIA PTY LTD, Import Fluticasone To?
Destination countries from 48 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $1.5M | 48 | 100.0% |
CIPLA AUSTRALIA PTY LTD, imports Fluticasone to 1 country. The primary destination is AUSTRALIA receiving 100.0% of shipments worth $1.5M.
What Fluticasone Formulations Does CIPLA AUSTRALIA PTY LTD, Import?
| Formulation | Value | Shipments |
|---|---|---|
| FLUTICASONE + SALMETEROL CIPLA 250/25 HF | $400.0K | 8 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 M | $150.0K | 3 |
| FLUTICASONE + SALMETEROL CIPLA 250/25 HFA INHALER (FLUTICASONE PROPIONATE 250MCG + SALMETEROL XINAFOATE 25MCG | $104.4K | 3 |
| FLUTICASONE + SALMETROL CIPLA 125 /25 HF | $100.0K | 2 |
| FLUTICASONE + SALMETEROL CIPLA 250/25 HFA INHALER (SALMETEROL XINAFOATE 25 MCG+FLUTICASONE PROPIONATE 250MCG INHALER) | $100.0K | 2 |
| FLUTICASONE SALMETEROL CIPHALER 500/50 | $80.1K | 3 |
| FLUTICASONE CIPLA INHALER 250 MCG ( FLUT | $59.0K | 3 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 MCG/DOSE SALMETEROL 50 MCG AND FLUTICASONE DOCUMENT QTY 9240 PACK 1X60S = 554 | $50.0K | 1 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 MCG/DOSE (SALMETEROL 50 MCG AND FLUTICASONE PROPIONATE 250MCG)(INV.QTY.8760 PACK | $50.0K | 1 |
| FLUTICASONE SALMETEROL CIPHALER 250/50 MCG/DOSE (SALMETEROL 50 MCG AND FLUTICASONE PROPIONATE 250MCG)(INV.QTY.8625 PACK | $50.0K | 1 |
CIPLA AUSTRALIA PTY LTD, imports 25 distinct Fluticasone formulations from India. The top formulation is FLUTICASONE + SALMETEROL CIPLA 250/25 HF with 8 shipments worth $400.0K.
Regulatory Requirements: Importing Fluticasone into Australia
What CIPLA AUSTRALIA PTY LTD, and other importers must comply with to import Fluticasone from India
Regulatory Authority
Therapeutic Goods Administration (TGA)
Approval Process for Generic Fluticasone
Application for registration on the Australian Register of Therapeutic Goods (ARTG). Generic pathway requires bioequivalence and quality data per TGA guidelines.
Typical timeline: 10–14 months
GMP Requirements
TGA GMP clearance; PIC/S-aligned inspection of overseas manufacturing facilities
Import Licence & Documentation
TGA manufacturing licence or sponsor licence for import; GMP clearance for each manufacturing site
Labeling & Packaging
Australian-specific labeling per TGO 91/92; English language; AUST R number
Note: TGA participates in PIC/S mutual recognition — PIC/S GMP certificate from India may expedite clearance.
Regulatory information is provided for general reference based on publicly available TGA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with TGA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Fluticasone from India and How Much Does CIPLA AUSTRALIA PTY LTD, Import?
India exported $55.6M worth of Fluticasone through 9,009 shipments from 239 suppliers to 123 countries, serving 664 buyers globally. CIPLA AUSTRALIA PTY LTD, imports $1.5M of this total, accounting for 0.7% of India's Fluticasone exports with 48 shipments from AUSTRALIA. This is verified from 48 customs shipment records covering 25 distinct formulations.
What Is the Average Order Value for CIPLA AUSTRALIA PTY LTD,'s Fluticasone Imports?
CIPLA AUSTRALIA PTY LTD,'s average Fluticasone order value is $31.0K per consignment, based on 48 shipments totaling $1.5M. CIPLA AUSTRALIA PTY LTD, is based in AUSTRALIA and ranks #11 among all Fluticasone importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Fluticasone to CIPLA AUSTRALIA PTY LTD,?
CIPLA AUSTRALIA PTY LTD, sources Fluticasone from 1 verified Indian supplier: CIPLA LIMITED ($1.5M, 100.0%). This is based on 48 customs records.
How Does CIPLA AUSTRALIA PTY LTD, Compare to Other Fluticasone Importers?
CIPLA AUSTRALIA PTY LTD, ranks #11 among 664 Fluticasone importers from India with a 0.7% market share. The top 3 importers are MYLAN IRELAND LTD ($17.4M), APOTEX INC ($7.9M), MYLAN IRELAND LIMITED ($6.8M). CIPLA AUSTRALIA PTY LTD, processed 48 shipments from AUSTRALIA.
What Other Respiratory Products Does CIPLA AUSTRALIA PTY LTD, Import?
CIPLA AUSTRALIA PTY LTD, also imports these respiratory products. Each links to the detailed product page.
About CIPLA AUSTRALIA PTY LTD,
CIPLA AUSTRALIA PTY LTD, imports 3 products worth $2.9M. Beyond Fluticasone, top products include Salmeterol, Lenalidomide. View the complete CIPLA AUSTRALIA PTY LTD, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluticasone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluticasone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CIPLA AUSTRALIA PTY LTD, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CIPLA AUSTRALIA PTY LTD,'s capped import value divided by total capped export value for Fluticasone across all Indian exporters.
- 5.Verified Records: This page is backed by 48 individual customs records matching CIPLA AUSTRALIA PTY LTD, importing Fluticasone, covering 25 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 664+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluticasone Import Data for CIPLA AUSTRALIA PTY LTD,
Access order-level details, pricing data, supplier connections, and competitive analysis for CIPLA AUSTRALIA PTY LTD,'s Fluticasone imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CIPLA AUSTRALIA PTY LTD,
Full Company Profile →
3 products · $2.9M total trade · 2 categories
CIPLA AUSTRALIA PTY LTD, × Fluticasone
Verified from customs records
Company Overview
Top Products by CIPLA AUSTRALIA PTY LTD,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CIPLA AUSTRALIA PTY LTD,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluticasone. For current order-level data, contact TransData Nexus.